Serum levels of the proinflammatory cytokine IL-1β showed significant correlation with the measures of disease severity only in children with epilepsy but not in acquired demyelinating disorders in the CNS, implicating IL-1β as a potential prognostic biomarker for childhood epilepsy as ongoing neuroinflammation. This evidence concerns the gene IL1B and epilepsy.